2SX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - scPharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 4.758 EUR Market Closed

Market Cap: €171.5m

S	scPharmaceuticals Inc F:2SX	US
A	Appian Corp F:910	US
V	Viking Mines Ltd F:AVI	AU
W	Way of Will Inc CNSX:WAY	CA
E	E&M Co Ltd KOSDAQ:089230	KR
	Bank Panin Dubai Syariah Tbk PT F:2PS	ID
M	Modetour Network Inc KOSDAQ:080160	KR
	Radient Technologies Inc F:RD8	CA
	Columbia Financial Inc F:64H	US
T	Troy Resources Ltd OTC:TRYRF	AU
	TNS Energo Mariy El PAO MOEX:MISBP	RU
D	Deutsche Grundstuecksauktionen vormals Berliner Grundstuecksauktionen AG SWB:DGR	DE

Profitability Summary

scPharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

70%

Declining Gross Margin

74% > 68%

Negative Operating Margin

-159%

Negative 3Y Average Operating Margin

-300%

Operating Margin is Increasing

-1 211% > -159%

Negative Net Margin

-184%

Negative 3Y Average Net Margin

-319%

Net Margin is Increasing

-1 210% > -184%

Negative Free Cash Flow Margin

-132%

Negative 3Y Average Free Cash Flow Margin

-316%

Free Cash Flow Margin is Increasing

-1 370% > -132%

Exceptional ROE

1 520%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-416%

ROIC is Increasing

-723% > -279%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.